Moderna Settlement And EMA Opinion Reframe mRNA Platform Outlook [Yahoo! Finance]
Arbutus Biopharma Corporation (ABUS)
Last arbutus biopharma corporation earnings: 11/6 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.arbutusbio.com/node/5806
Company Research
Source: Yahoo! Finance
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Moderna (NasdaqGS:MRNA) has reached a global settlement with Genevant Sciences and Arbutus Biopharma over lipid nanoparticle technology used in its Covid 19 vaccines. The agreement includes a substantial upfront payment, a non exclusive license, and removes the prospect of future royalties for infectious disease applications. At the same time, Moderna received a positive opinion from the European Medicines Agency for its influenza Covid 19 combination vaccine, mCombriax. These decisions reshape the company's legal, financial, and product profile and could set up a new chapter for its mRNA platform in Europe and beyond. For you as an investor, this is a double header: a long running patent dispute tied to Moderna's Covid 19 products now has a defined outcome, and its combination vaccine has cleared a key regulatory hurdle in Europe. Mo
Show less
Read more
Impact Snapshot
Event Time:
ABUS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABUS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABUS alerts
High impacting Arbutus Biopharma Corporation news events
Weekly update
A roundup of the hottest topics
ABUS
News
- Why Moderna (MRNA) Stock Is Trading Up Today [Yahoo! Finance]Yahoo! Finance
- Moderna Stock Pops After Inking $950 Million Covid Vaccine Settlement [Yahoo! Finance]Yahoo! Finance
- Moderna gains as Arbutus/ Genevant settlement removes major financial risk [Seeking Alpha]Seeking Alpha
- Moderna shares jump as settlement removes major legal overhang [Yahoo! Finance]Yahoo! Finance
- Genevant Sciences and Arbutus Biopharma Announce $2.25 Billion Global Settlement With ModernaGlobeNewswire
ABUS
Earnings
- 8/6/25 - Beat
ABUS
Sec Filings
- 3/3/26 - Form 8-K
- 2/20/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- ABUS's page on the SEC website